Predicting cancer drug responses before clinical trials begin
AlphaGrid uses AI and patient-derived organoids to build digital twins of tumors, testing drug responses before clinical trials even begin.
We haven't written up this one. Tech in Asia has the full story — the link below goes straight to it.